BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11576343)

  • 1. Increased expression of heparanase in puromycin aminonucleoside nephrosis.
    Levidiotis V; Kanellis J; Ierino FL; Power DA
    Kidney Int; 2001 Oct; 60(4):1287-96. PubMed ID: 11576343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered expression of NDST-1 messenger RNA in puromycin aminonucleoside nephrosis.
    Nakayama K; Natori Y; Sato T; Kimura T; Sugiura A; Sato H; Saito T; Ito S; Natori Y
    J Lab Clin Med; 2004 Feb; 143(2):106-14. PubMed ID: 14966466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a low-protein diet on expression of non-muscle type myosin heavy-chain isoforms in glomeruli of rats with puromycin aminonucleoside nephrosis.
    Koide H; Nakamura T; Kimura K; Ebihara I; Nagai R; Tomino Y
    Nephrol Dial Transplant; 1996 Sep; 11(9):1769-74. PubMed ID: 8918620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparanase inhibition reduces proteinuria in a model of accelerated anti-glomerular basement membrane antibody disease.
    Levidiotis V; Freeman C; Tikellis C; Cooper ME; Power DA
    Nephrology (Carlton); 2005 Apr; 10(2):167-73. PubMed ID: 15877677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glomerular expression of smooth-muscle myosin heavy-chain isoforms in aminonucleoside nephrosis in rats.
    Nakamura T; Kimura K; Ebihara I; Takahashi T; Tomino Y; Aikawa M; Yazaki Y; Nagai R; Koide H
    Clin Sci (Lond); 1995 Jul; 89(1):45-52. PubMed ID: 7671567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of cyclosporin on podocyte ZO-1 expression in puromycin aminonucleoside nephrosis rats.
    Kim BS; Park HC; Kang SW; Choi KH; Ha SK; Han DS; Lee HY
    Yonsei Med J; 2005 Feb; 46(1):141-8. PubMed ID: 15744817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics of absolute amount of nephrin in a single podocyte in puromycin aminonucleoside nephrosis rats calculated by quantitative glomerular proteomics approach with selected reaction monitoring mode.
    Kawakami H; Kamiie J; Yasuno K; Kobayashi R; Aihara N; Shirota K
    Nephrol Dial Transplant; 2012 Apr; 27(4):1324-30. PubMed ID: 21862459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bone mesenchymal stem cell transplantation repairs glomerular podocytes in rats with puromycin aminonucleoside-induced nephrosis].
    Yang HD; Dong C; Guan FJ; Gao LL; Zhao T; Feng BF
    Zhongguo Dang Dai Er Ke Za Zhi; 2010 Jun; 12(6):483-7. PubMed ID: 20540862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Podoplanin, novel 43-kd membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis.
    Breiteneder-Geleff S; Matsui K; Soleiman A; Meraner P; Poczewski H; Kalt R; Schaffner G; Kerjaschki D
    Am J Pathol; 1997 Oct; 151(4):1141-52. PubMed ID: 9327748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluvastatin ameliorates podocyte injury in proteinuric rats via modulation of excessive Rho signaling.
    Shibata S; Nagase M; Fujita T
    J Am Soc Nephrol; 2006 Mar; 17(3):754-64. PubMed ID: 16452496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of VEGF and its receptors in two rat models of proteinuria.
    Kanellis J; Levidiotis V; Khong T; Cox AJ; Stacker SA; Gilbert RE; Cooper ME; Power DA
    Nephron Physiol; 2004; 96(1):P26-36. PubMed ID: 14752241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Fat1 in cell-cell contact formation of podocytes in puromycin aminonucleoside nephrosis and neonatal kidney.
    Yaoita E; Kurihara H; Yoshida Y; Inoue T; Matsuki A; Sakai T; Yamamoto T
    Kidney Int; 2005 Aug; 68(2):542-51. PubMed ID: 16014031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glomerular epithelial detachment, not reduced charge density, correlates with proteinuria in adriamycin and puromycin nephrosis.
    Whiteside C; Prutis K; Cameron R; Thompson J
    Lab Invest; 1989 Dec; 61(6):650-60. PubMed ID: 2601299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A scanning and transmission electron microscopic comparison of puromycin aminonucleoside-induced nephrosis to hyperalbuminemia-induced proteinuria with emphasis on kidney podocyte pedicel loss.
    Andrews PM
    Lab Invest; 1977 Feb; 36(2):183-97. PubMed ID: 839733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decrease of glomerular disialogangliosides in puromycin nephrosis of the rat.
    Holthöfer H; Reivinen J; Solin ML; Haltia A; Miettinen A
    Am J Pathol; 1996 Sep; 149(3):1009-15. PubMed ID: 8780404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressed activities of cathepsins and metalloproteinases in the chronic model of puromycin aminonucleoside nephrosis.
    Huang S; Schaefer RM; Reisch S; Paczek L; Schaefer L; Teschner M; Sebekova K; Heidland A
    Kidney Blood Press Res; 1999; 22(3):121-7. PubMed ID: 10394110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel expression of sodium/myo-inositol co-transporter in podocytes in puromycin aminonucleoside nephrosis.
    Watanabe Y; Kobayashi T; Yaoita E; Kawachi H; Yamauchi A; Inoue T; Shimizu F; Yoshida Y; El-Shemi AG; Okada H; Suzuki H; Yamamoto T
    Nephrol Dial Transplant; 2004 Apr; 19(4):817-22. PubMed ID: 15031335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of heparin-binding epidermal growth factor-like growth factor increases albuminuria in puromycin aminonucleoside nephrosis.
    Khong TF; Fraser S; Katerelos M; Paizis K; Hill PA; Power DA
    Kidney Int; 2000 Sep; 58(3):1098-107. PubMed ID: 10972674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of basement membrane component gene expression in glomeruli of aminonucleoside nephrosis.
    Nakamura T; Ebihara I; Shirato I; Tomino Y; Koide H
    Lab Invest; 1991 May; 64(5):640-7. PubMed ID: 2030578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renoprotective effect of the L/N-type calcium channel antagonist cilnidipine on puromycin aminonucleoside-induced nephrosis in rats.
    Takashima K; Nishiyama C; Arisaka N; Takahashi T; Souma S; Tsuda M; Hayashi M; Kasahara H; Kodama H; Tamura T; Murakami M; Kuroda J; Sato F
    Arzneimittelforschung; 2009; 59(2):79-85. PubMed ID: 19338138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.